CVR 18652439Public limited company (A/S)Virksomhedsrådgivning og anden ledelsesrådgivning (702000)Kongens LyngbyFounded 1 Jul 1995
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about PharmaLex Denmark A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
15
CVR registry, Aug 2026
-6 (-28.6%) over 12 months
Gross profit
17.2M
DKK, annual report 2025
-33.8% on 2024
Result
-1.7M
DKK, annual report 2025
Equity
2.8M
DKK, annual report 2025
Pharmalex Nordic ApSCVR 37541540, 100% of capital and votes, since 5 Jul 2016
Åsa Pihlbladsince 1 Oct 2024
CVR 37541540100% of capital and votesnotified 6 Nov 2017since 5 Jul 2016
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 18960788100% of capital and votes5 May 2003 to 4 Jul 2016
100% of capital and votes13 Nov 2020 to 13 Nov 2020
Ultimate controller
AmerisourceBergen International B.V.
Holds 100% of capital and votes in Pharmalex Nordic ApS, since 27 Jul 2023
Holding company
CVR 37541540Private limited company (ApS)
Holds 100% of capital and votes in PharmaLex Denmark A/S, since 5 Jul 2016
This company
PharmaLex Denmark A/S
CVR 18652439
PharmaLex Denmark A/S holds no Danish company now.
Found by searching the CVR owner register (ejerregister) for PharmaLex Denmark A/S as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 33163304100% of capital and votes25 Apr 2017 to 2 Jun 2017
CVR records founders at incorporation. It does not record whether they are alive or still involved.
25 May 2023 to 4 Nov 2026.
1 Jul 1995 to 4 Nov 2026.
Aug 2026, monthly: 15 employees, 14 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 12 | 10 | 11 | No count | No count | No count | No count | 8 | 11 | 15 | 19 | 23 | 24 | 23 | 23 | 26 | 25 | 25 | 27 | 27 | 28 | 26 | 25 | 26 | 25 | 24 | 23 | 23 | 23 | 20 | 20 | 20 | 18 | 18 | 18 | 24 | 25 | 25 | 23 | 23 | 22 | 21 | 23 | 22 | 22 | 22 | 20 | 19 | 17 | 15 | 13 | 14 | 14 | 14 | 15 | 15 | 16 | 16 | 15 | 14 | 15 | 16 | 17 | 17 | 18 | 18 | 18 | 19 | 19 | 20 | 20 | 22 | 24 | 23 | 23 | 24 | 24 | 23 | 23 | 24 | 23 | 22 | 22 | 24 | 24 | 23 | 23 | 23 | 23 | 24 | 23 | 27 | 28 | 27 | 28 | 29 | 30 | 30 | 30 | 29 | 27 | 28 | 28 | 29 | 30 | 30 | 30 | 30 | 32 | 27 | 27 | 25 | 25 | 27 | 27 | 27 | 26 | 29 | 24 | 24 | 25 | 25 | 25 | 25 | 26 | 26 | 25 | 25 | 24 | 26 | 26 | 27 | 24 | 24 | 23 | 21 | 20 | 22 | 21 | 21 | 21 | 21 | 19 | 17 | 17 | 17 | 17 | 17 | 17 | 15 | 15 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 7 | 9 | 10 | 11 | 9 | 9 | 9 | 7 | 9 | 13 | 17 | 20 | 19 | 20 | 18 | 23 | 22 | 22 | 23 | 24 | 25 | 23 | 22 | 22 | 22 | 21 | 20 | 18 | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 22 | 23 | 22 | 21 | 20 | 19 | 19 | 20 | 19 | 19 | 19 | 17 | 16 | 15 | 13 | 12 | 13 | 13 | 13 | 14 | 14 | 15 | 15 | 14 | 13 | 14 | 15 | 15 | 16 | 17 | 17 | 17 | 18 | 17 | 20 | 20 | 22 | 23 | 22 | 22 | 23 | 23 | 21 | 22 | 23 | 22 | 21 | 22 | 23 | 24 | 22 | 23 | 23 | 22 | 23 | 22 | 26 | 28 | 26 | 27 | 29 | 29 | 28 | 30 | 28 | 26 | 27 | 27 | 28 | 29 | 29 | 30 | 29 | 32 | 26 | 27 | 25 | 24 | 26 | 24 | 26 | 26 | 26 | 24 | 24 | 25 | 25 | 25 | 25 | 26 | 26 | 25 | 25 | 24 | 25 | 25 | 25 | 24 | 23 | 23 | 21 | 20 | 21 | 21 | 21 | 21 | 20 | 18 | 17 | 17 | 17 | 17 | 17 | 15 | 15 | 14 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 1997 to 2009 and 2011 to 2014; quarterly Q1 2010 to Q4 2010; monthly Jan 2015 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 22,718 | 29,957 | 20,503 | 26,015 | 17,235 |
| Operating profit | +3,252 | +7,393 | +1,606 | +2,251 | -2,167 |
| Result for the year | +2,634 | +5,780 | +1,244 | +1,746 | -1,712 |
| Equity | 3,853 | 6,583 | 5,228 | 5,973 | 2,761 |
| Total assets | 11,309 | 12,896 | 13,125 | 12,543 | 18,307 |
| Employees (average) | 25 | 29 | 26 | 25 | 18 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 5.5% | 31.9% | Not reportednote 1 | Not reportednote 1 | -33.8% |
| EBITDA | 3,364 | 7,484 | 1,674 | 2,359 | -2,076 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 14.8% | 25% | 8.2% | 9.1% | -12% |
| Employee growth (vækst i antal ansatte) | 8.7% | 16% | Not reportednote 1 | Not reportednote 1 | -28% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -715 | -6,847 | -6,912 | -6,564 | -8,468 |
| Gearing, NIBD / EBITDA | Net cash | Net cash | Not reportednote 1 | Net cash | n.m.note 2 |
| ROIC (afkast af investeret kapital) | 82.8% | 407.1% | Not reportednote 1 | n.m.note 3 | n.m.note 3 |
| Capex (investeringer i anlægsaktiver) | 61note 4 | 138note 4 | 99note 4 | 56note 4 | 113note 4 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -5,406 | -6,954 | -7,097 | -4,924 | 2,211 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2023 covers 9 months (1 Jan to 30 Sep 2023). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Oct 2024 to 30 Sep 2025, published 31 Mar 2026
Annual report 2024
1 Oct 2023 to 30 Sep 2024, published 20 Feb 2025
Annual report 2023
1 Jan 2023 to 30 Sep 2023, published 26 Jan 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 15 Mar 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 18 Mar 2022
Each registered value from the day it took effect, newest first.
Merger (Fusion), as the continuing company (Fortsættende selskab)
From CVR, read 4 Nov 2026. Text such as the signing rule and purpose is shown as registered.
33 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 22.09.2026
Kapitalforhøjelsen er besluttet den 22.09.2026.
kr. 1.000,00, indbetalt kontant, kurs 448.530,00.
Kapitalen udgør herefter kr. 551.000,00.
Bestyrelse:
Fratrådte:
Eva Edil, den 04.05.2026.
Tiltrådte:
Carlos Antonio Santaflorentina Juanino, den 04.05.2026.
Ny adresse: Lyngby Hovedgade 10C, 2800 Kongens Lyngby
Ny kommune: Lyngby-Taarbæk
Bestyrelse:
Fratrådte:
Laurent Maurice Robert Couston, den 31.10.2024.
Tiltrådte:
Eva Edil, den 31.10.2024.
Direktion:
Fratrådte:
Torben Thers Nørgaard, (adm. dir), den 01.10.2024.
Tiltrådte:
Åsa Pihlblad, (adm. dir), den 01.10.2024.
Bestyrelse:
Fratrådte:
Eva Edil, den 25.05.2023, Dr. Thomas Stefan Dobmeyer, (formand), den 25.05.2023.
Tiltrådte:
Christopher Gauglitz, (formand), den 25.05.2023, Laurent Maurice Robert Couston, den 25.05.2023.
Vedtægter ændret: 09.05.2023
Regnskabsår ændret til: 01.10 - 30.09
Omlægningsperiode: 01.01.2023 - 30.09.2023
Bestyrelse:
Fratrådte:
Anette Langgaard Jacobsen (formand), den 20.03.2018, Dr. Thomas Stefan Dobmeyer, den 20.03.2018.
Tiltrådte:
Eva Edil, den 20.03.2018, Dr. Thomas Stefan Dobmeyer (formand), den 20.03.2018.
Bestyrelse:
Fratrådte:
Solveig Blomvik, den 17.01.2018.
Tiltrådte:
Dr. Thomas Stefan Dobmeyer, den 17.01.2018.
Vedtægter ændret: 06.11.2017
Nyt navn: PharmaLex Denmark A/S
Nyt binavn: JACOBSEN PHARMA CONSULTANCY A/S
Slettet binavn: PharmaLex Denmark A/S
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er fusioneret med CVR-nummer: 33163304 LINDEQ DK A/S, der samtidigt er opløst.
Vedtægter ændret: 02.06.2017
Nyt binavn: Lindeq DK A/S
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 18652439 JACOBSEN PHARMA CONSULTANCY A/S (fortsættende), der tillige driver virksomhed under navnene JACOBSEN PHARMA A/S, JACOBSEN PHARMA & MEDICO A/S, JACOBSEN REGULATORY CONSULTING A/S, JACOBSEN PHARMA & MEDTECH ADVICE A/S, PharmaLex Denmark A/S og CVR-nummer: 33163304 LINDEQ DK A/S (ophørende).
Kapitalejerne i CVR-nummer: 18652439 JACOBSEN PHARMA CONSULTANCY A/S og CVR-nummer: 33163304 LINDEQ DK A/S har i enighed besluttet, at der ikke skal udarbejdes en erklæring om kreditorernes stilling i forbindelse med fusionen. Kreditorer, hvis fordringer er stiftet forud for bekendtgørelsen om fusionen, og for hvilke der ikke er stillet særskilt sikkerhed, kan anmelde deres fordringer senest 4 uger efter denne offentliggørelse.
Vedtægter ændret: 01.01.2017
Ny adresse: Agern Alle 24, 2970 Hørsholm
Ny kommune: Rudersdal
Nyt binavn: PharmaLex Denmark A/S
Bestyrelse:
Fratrådte:
Anette Langgaard Jacobsen, den 01.01.2017, Caren Ingrid Martini, den 01.01.2017, Raphael Troost (formand), den 01.01.2017.
Tiltrådte:
Solveig Blomvik, den 01.01.2017, Anette Langgaard Jacobsen (formand), den 01.01.2017, Torben Thers Nørgaard, den 01.01.2017.
Direktion:
Fratrådte:
Anette Langgaard Jacobsen, den 01.01.2017.
Tiltrådte:
Torben Thers Nørgaard (adm. dir), den 01.01.2017.
Revision:
Fratrådte:
SØNDERJYLLANDS REVISION STATSAUTORISERET REVISIONSAKTIESELSKAB, den 20.10.2016.
Tiltrådte:
CVR-NR. 32895468 BEIERHOLM, STATSAUTORISERET REVISIONSPARTNERSELSKAB, Gribskovvej 2, 2100 København Ø, den 20.10.2016.
Bestyrelse:
Fratrådte:
Henrik Kagenow (formand), den 05.07.2016, Jakob Langgaard Wisnewski, den 05.07.2016.
Tiltrådte:
Caren Ingrid Martini, den 05.07.2016, Raphael Troost (formand), den 05.07.2016.
Bestyrelse:
Fratrådte:
Elsebeth Budolfsen, den 16.03.2016, Henrik Kagenow, den 16.03.2016.
Tiltrådte:
Anette Langgaard Jacobsen, den 16.03.2016, Henrik Kagenow (formand), den 16.03.2016.
Vedtægter ændret:
07.11.2013.
Nyt binavn: JACOBSEN PHARMA & MEDTECH ADVICE A/S.
Vedtægter ændret:
22.10.2013.
Nye binavne:
JACOBSEN PHARMA & MEDICO A/S, JACOBSEN REGULATORY CONSULTING A/S.
Bestyrelse:
Udtrådt af bestyrelsen:
Niels Bjerregaard, den 26.06.2012.
Indtrådt i bestyrelsen:
Adm. direktør Henrik Kagenow, den 26.06.2012.
Revision:
Udtrådt af revisionen:
CVR-NR. 28661754 SØNDERJYLLANDS REVISION SØNDERBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 22.10.2010.
Indtrådt i revisionen:
SØNDERJYLLANDS REVISION STATSAUTORISERET REVISIONSAKTIESELSKAB, Jyllandsgade 30, 6400 Sønderborg, den 22.10.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Per Egebæk Have, den 25.03.2010.
Indtrådt i bestyrelsen:
Niels Bjerregaard, den 25.03.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Laurits Thorvald Larsen, den 16.06.2008.
Indtrådt i bestyrelsen:
Jakob Langgaard Wisnewski, den 16.06.2008.
Revision:
Udtrådt af revisionen:
Erik Peter Andersen, den 16.06.2008.
Indtrådt i revisionen:
CVR-NR. 28661754 SØNDERJYLLANDS REVISION SØNDERBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB, Jyllandsgade 30, 6400 Sønderborg, den 16.06.2008.
Bestyrelse:
Udtrådt af bestyrelsen:
Finn Wisnewski, den 13.06.2007.
Indtrådt i bestyrelsen:
Økonomidirektør Per Egebæk Have, den 13.06.2007.
Ved kommunalreformen den 1. januar 2007 er hjemstedskommunen ændret.
Vedtægter ændret:
02.10.2006.
Ny adresse:
Nørre Havnegade 108, 6400 Sønderborg.
Ny kommune:
Sønderborg.
Bestyrelse:
Udtrådt af bestyrelsen:
Michael Clemmensen, den 10.06.2006, Anette Langgaard Jacobsen, den 10.06.2006.
Indtrådt i bestyrelsen:
Adm. direktør Elsebeth Budolfsen, den 10.06.2006, Laurits Thorvald Larsen, den 10.06.2006.
Revision:
Udtrådt af revisionen:
Leif Ove Rasmussen, den 30.07.2002.
Indtrådt i revisionen:
Registreret revisor Erik Peter Andersen, 6400 Sønderborg, den 30.07.2002.
Vedtægter ændret:
20.06.2002.
Kapitalforhøjelse:
kr. 50.000,00 indbetalt kontant, kurs 1.200,00.
Kapitalen udgør herefter kr. 550.000,00.
Ny kommune:
Broager.
Vedtægter ændret:
16.01.1996.
Ny adresse:
Vemmingbundstrandvej 111, 6310 Broager.
Nyt binavn: JACOBSEN PHARMA A/S (JACOBSEN PHARMA CONSULTANCY A/S).
Vedtægter ændret:
31.08.1995.
Nyt navn:
JACOBSEN PHARMA CONSULTANCY A/S.
Ny adresse:
Toderupvej 26, 5471 Søndersø.
Ny kommune:
Søndersø.
Bestyrelse:
Udtrådt af bestyrelsen:
Mogens Gaardboe Bertelsen, den 31.08.1995, Preben Bang Henriksen, den 31.08.1995, Lone Mai Henriksen, den 31.08.1995.
Indtrådt i bestyrelsen:
Advokat Michael Clemmensen, den 31.08.1995, Annette Langgaard Jacobsen, den 31.08.1995, Finn Wisnewski, den 31.08.1995.
Direktion:
Udtrådt af direktionen:
Preben Bang Henriksen, den 31.08.1995.
Indtrådt i direktionen:
Annette Langgaard Jacobsen, den 31.08.1995.
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af en direktør.
Revision:
Udtrådt af revisionen:
Harry Aamann, den 31.08.1995.
Indtrådt i revisionen:
Statsaut. revisor Leif Ove Rasmussen, 6630 Rødding, den 31.08.1995.
Stiftelsesdato:
01.07.1995.
Seneste vedtægtsdato:
01.07.1995.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
REG.NR. ApS176548 PREBEN BANG HENRIKSEN, AALBORG ApS, c/o adv. Preben Bang Henriksen, Slotspladsen 2, 9000 Aalborg.
Bestyrelse:
Mogens Gaardboe Bertelsen (formand), Advokat Preben Bang Henriksen, Lone Mai Henriksen.
Direktion:
Advokat Preben Bang Henriksen.
Selskabet tegnes af den samlede bestyrelse eller af en direktør.
Revision:
Statsaut. revisor Harry Aamann, 9200 Aalborg SV.
Første regnskabsår:
01.07.1995 - 31.12.1996.
Regnskabsår:
01.01 - 31.12.
4 registered in CVR.
P-number 1006003140111, 9999 Ukendt
P-number 1019505673Lyngby Hovedgade 10, 2800 Kongens Lyngby
P-number 1022135364Lyskær 8, 2730 Herlev
P-number 1003642261Grundtvigs Alle 181, 6400 Sønderborg
No other current company drawn.
No other current company drawn.